Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,580,000 | 9,698,000 | 1,970,000 | 7,703,000 | 5,727,000 |
| Depreciation Amortization | 3,526,000 | N/A | N/A | 6,332,000 | 4,608,000 |
| Income taxes - deferred | 1,182,000 | N/A | -389,000 | 1,296,000 | 971,000 |
| Accounts receivable | N/A | N/A | N/A | -204,000 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 58,000 | N/A |
| Other Working Capital | -1,086,000 | -1,378,000 | -829,000 | 244,000 | -1,681,000 |
| Other Operating Activity | -4,696,000 | -1,864,000 | 1,762,000 | -2,808,000 | -412,000 |
| Operating Cash Flow | $10,506,000 | $6,456,000 | $2,514,000 | $12,621,000 | $9,213,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,000 | 68,000 | 12,000 | -31,000 | -24,000 |
| PPE Investments | -755,000 | -464,000 | -213,000 | -1,604,000 | -996,000 |
| Net Acquisitions | 582,000 | -12,132,000 | -3,644,000 | -895,000 | -856,000 |
| Purchase Of Investment | -148,000 | 12,929,000 | -33,000 | -468,000 | -291,000 |
| Sale Of Investment | 138,000 | 64,000 | 9,000 | 330,000 | 273,000 |
| Purchase Sale Intangibles | -486,000 | -226,000 | -222,000 | -410,000 | -178,000 |
| Other Investing Activity | -505,000 | -235,000 | -226,000 | -451,000 | -229,000 |
| Investing Cash Flow | $-656,000 | $230,000 | $-4,095,000 | $-3,119,000 | $-2,123,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,199,000 | 1,802,000 | 2,451,000 | -755,000 | 694,000 |
| Debt Issued | 2,856,000 | 2,856,000 | 2,765,000 | 4,933,000 | 4,933,000 |
| Debt Repayment | -366,000 | -365,000 | 0 | -188,000 | -188,000 |
| Common Stock Issued | N/A | N/A | 433,000 | 252,000 | N/A |
| Common Stock Repurchased | -1,787,000 | -774,000 | -175,000 | -5,490,000 | -4,564,000 |
| Dividend Paid | -6,549,000 | -6,706,000 | -6,962,000 | -6,485,000 | -6,445,000 |
| Other Financing Activity | -50,000 | 111,000 | -58,000 | 0 | 233,000 |
| Financing Cash Flow | $-4,697,000 | $-3,076,000 | $-1,546,000 | $-7,733,000 | $-5,337,000 |
| Exchange Rate Effect | -13,000 | -24,000 | 80,000 | 84,000 | 50,000 |
| Beginning Cash Position | 8,860,000 | 8,860,000 | 8,860,000 | 7,007,000 | 7,007,000 |
| End Cash Position | 14,000,000 | 12,446,000 | 5,813,000 | 8,860,000 | 8,810,000 |
| Net Cash Flow | $5,140,000 | $3,586,000 | $-3,047,000 | $1,853,000 | $1,803,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,506,000 | 6,456,000 | 2,514,000 | 12,621,000 | 9,213,000 |
| Capital Expenditure | -810,000 | -515,000 | -258,000 | -1,696,000 | -1,058,000 |
| Free Cash Flow | 9,696,000 | 5,941,000 | 2,256,000 | 10,925,000 | 8,155,000 |